These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 36817426)

  • 1. Evolutive emergence and divergence of an Ig regulatory node: An environmental sensor getting cues from the aryl hydrocarbon receptor?
    D'Addabbo P; Frezza D; Sulentic CEW
    Front Immunol; 2023; 14():996119. PubMed ID: 36817426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: Evolutive emergence and divergence of an Ig regulatory node: an environmental sensor getting cues from the aryl hydrocarbon receptor?
    Frontiers Production Office
    Front Immunol; 2023; 14():1356336. PubMed ID: 38250069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential activation and distinct functions for distal and proximal modules within the IgH 3' regulatory region.
    Garot A; Marquet M; Saintamand A; Bender S; Le Noir S; Rouaud P; Carrion C; Oruc Z; Bébin AG; Moreau J; Lebrigand K; Denizot Y; Alt FW; Cogné M; Pinaud E
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1618-23. PubMed ID: 26831080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.
    Henseler RA; Romer EJ; Sulentic CE
    Toxicology; 2009 Jun; 261(1-2):9-18. PubMed ID: 19447539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class-Switch Recombination in the Absence of the IgH 3' Regulatory Region.
    Kim A; Han L; Santiago GE; Verdun RE; Yu K
    J Immunol; 2016 Oct; 197(7):2930-5. PubMed ID: 27559052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene.
    Wourms MJ; Sulentic CE
    Cell Immunol; 2015 May; 295(1):60-6. PubMed ID: 25749007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The IgH 3'RR: Doctor Jekyll and Mister Hyde of B-cell maturation and lymphomagenesis].
    Saintamand A; Ghazzaui N; Issaoui H; Denizot Y
    Med Sci (Paris); 2017 Nov; 33(11):963-970. PubMed ID: 29200394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination.
    Delgado-Benito V; Rosen DB; Wang Q; Gazumyan A; Pai JA; Oliveira TY; Sundaravinayagam D; Zhang W; Andreani M; Keller L; Kieffer-Kwon KR; Pękowska A; Jung S; Driesner M; Subbotin RI; Casellas R; Chait BT; Nussenzweig MC; Di Virgilio M
    Mol Cell; 2018 Nov; 72(4):636-649.e8. PubMed ID: 30293785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IgH 3' regulatory region influences lymphomagenesis in Igλ-Myc mice.
    Saad F; Saintamand A; Cogné M; Denizot Y
    Oncotarget; 2015 Aug; 6(24):20302-11. PubMed ID: 25980500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental Switch in the Transcriptional Activity of a Long-Range Regulatory Element.
    Braikia FZ; Conte C; Moutahir M; Denizot Y; Cogné M; Khamlichi AA
    Mol Cell Biol; 2015 Oct; 35(19):3370-80. PubMed ID: 26195822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IgH 3' regulatory region governs μ chain transcription in mature B lymphocytes and the B cell fate.
    Saintamand A; Rouaud P; Garot A; Saad F; Carrion C; Oblet C; Cogné M; Pinaud E; Denizot Y
    Oncotarget; 2015 Mar; 6(7):4845-52. PubMed ID: 25742787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IgH 3' regulatory region and its implication in lymphomagenesis.
    Vincent-Fabert C; Fiancette R; Cogné M; Pinaud E; Denizot Y
    Eur J Immunol; 2010 Dec; 40(12):3306-11. PubMed ID: 21080376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aryl hydrocarbon receptor differentially modulates the expression profile of antibody isotypes in a human B-cell line.
    Bhakta-Yadav MS; Burra K; Alhamdan N; Allex-Buckner CP; Sulentic CEW
    Toxicol Sci; 2024 May; 199(2):276-288. PubMed ID: 38526216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoglobulin heavy chain super enhancer controls class switch recombination in developing B cells.
    Dauba A; Näser E; Andrieux D; Cogné M; Denizot Y; Khamlichi AA
    Sci Rep; 2024 Mar; 14(1):7370. PubMed ID: 38548819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the importance of the palindromic architecture of the immunoglobulin heavy-chain 3' regulatory region.
    Saintamand A; Vincent-Fabert C; Garot A; Rouaud P; Oruc Z; Magnone V; Cogné M; Denizot Y
    Nat Commun; 2016 Feb; 7():10730. PubMed ID: 26883548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3'Regulatory Region.
    D'Addabbo P; Scascitelli M; Giambra V; Rocchi M; Frezza D
    BMC Evol Biol; 2011 Mar; 11():71. PubMed ID: 21406099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
    Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
    J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E
    Saintamand A; Vincent-Fabert C; Marquet M; Ghazzaui N; Magnone V; Pinaud E; Cogné M; Denizot Y
    Sci Rep; 2017 Mar; 7(1):442. PubMed ID: 28348365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunoglobulin heavy chain 3' regulatory region superenhancer controls mouse B1 B-cell fate and late VDJ repertoire diversity.
    Ghazzaui N; Issaoui H; Saintamand A; Oblet C; Carrion C; Denizot Y
    Blood Adv; 2018 Feb; 2(3):252-262. PubMed ID: 29437640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.